Shareholders' Equity

3 Months Ended

Mar. 31, 2016

Stockholders' Equity Note [Abstract]

Shareholders' Equity [Text Block]

Shareholders’ Equity

The following tables provide the amounts related to each component of other comprehensive income (loss) (“OCI”):

	Three Months Ended March 31, 2016
	Pretax			Income Tax Benefit (Expense)			Net of Tax
	(in millions)
Net unrealized securities gains:
Net unrealized securities gains arising during the period (1)	$	493		$	(173	)	$	320
Reclassification of net securities losses included in net income (2)	1			—			1
Impact of deferred acquisition costs, deferred sales inducement costs, unearned revenue, benefit reserves and reinsurance recoverables	(197		)	69			(128		)
Net unrealized securities gains	297			(104		)	193
Net unrealized derivatives gains:
Reclassification of net derivative losses included in net income (3)	1			—			1
Net unrealized derivatives gains	1			—			1
Foreign currency translation	(17		)	6			(11		)
Total other comprehensive income	$	281		$	(98	)	$	183

	Three Months Ended March 31, 2015
	Pretax			Income Tax Benefit (Expense)			Net of Tax
	(in millions)
Net unrealized securities gains:
Net unrealized securities gains arising during the period (1)	$	228		$	(81	)	$	147
Reclassification of net securities gains included in net income (2)	(11		)	4			(7		)
Impact of deferred acquisition costs, deferred sales inducement costs, unearned revenue, benefit reserves and reinsurance recoverables	(106		)	37			(69		)
Net unrealized securities gains	111			(40		)	71
Net unrealized derivatives gains:
Reclassification of net derivative losses included in net income (3)	—			—			—
Net unrealized derivatives gains	—			—			—
Foreign currency translation	(48		)	19			(29		)
Other comprehensive income attributable to Ameriprise Financial	63			(21		)	42
Other comprehensive loss attributable to noncontrolling interests	(86		)	30			(56		)
Total other comprehensive loss	$	(23	)	$	9		$	(14	)

⁽¹⁾ Includes other-than-temporary impairment losses on Available-for-Sale securities related to factors other than credit that were recognized in other comprehensive income (loss) during the period.

⁽²⁾ Reclassification amounts are recorded in net investment income.

⁽³⁾ Includes nil and a $1 million pretax gain reclassified to interest and debt expenses for the three months ended March 31, 2016 and 2015, respectively, and a $1 million pretax loss reclassified to net investment income for both the three months ended March 31, 2016 and 2015.

Other comprehensive income (loss) related to net unrealized securities gains (losses) includes three components: (i) unrealized gains (losses) that arose from changes in the market value of securities that were held during the period; (ii) (gains) losses that were previously unrealized, but have been recognized in current period net income due to sales of Available-for-Sale securities and due to the reclassification of noncredit other-than-temporary impairment losses to credit losses; and (iii) other adjustments primarily consisting of changes in insurance and annuity asset and liability balances, such as DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables, to reflect the expected impact on their carrying values had the unrealized gains (losses) been realized as of the respective balance sheet dates.

The following table presents the changes in the balances of each component of AOCI, net of tax:

	Net Unrealized Securities Gains				Net Unrealized Derivatives Gains		Defined Benefit Plans			Foreign Currency Translation			Total
	(in millions)
Balance, January 1, 2015	$	786			$	—	$	(71	)	$	(53	)	$	662
OCI before reclassifications	78				—		—			(29		)	49
Amounts reclassified from AOCI	(7		)		—		—			—			(7		)
OCI attributable to Ameriprise Financial	71				—		—			(29		)	42
Balance, March 31, 2015	$	857		(1)	$	—	$	(71	)	$	(82	)	$	704
Balance, January 1, 2016	$	426			$	1	$	(91	)	$	(83	)	$	253
Cumulative effect of change in accounting policies	6				—		—			—			6
Balance, January 1, 2016, as adjusted	432				1		(91		)	(83		)	259
OCI before reclassifications	192				—		—			(11		)	181
Amounts reclassified from AOCI	1				1		—			—			2
OCI attributable to Ameriprise Financial	193				1		—			(11		)	183
Balance, March 31, 2016	$	625		(1)	$	2	$	(91	)	$	(94	)	$	442

⁽¹⁾ Includes $(1) million and $5 million of noncredit related impairments on securities and net unrealized securities gains (losses) on previously impaired securities at March 31, 2016 and 2015, respectively.

For the three months ended March 31, 2016 and 2015, the Company repurchased a total of 5.1 million shares and 2.6 million shares, respectively, of its common stock for an aggregate cost of $451 million and $349 million, respectively. In April 2014, the Company's Board of Directors authorized an expenditure of up to $2.5 billion for the repurchase of shares of the Company’s common stock through April 28, 2016, which was exhausted in the three months ended March 31, 2016. In December 2015, the Company’s Board of Directors authorized additional expenditures of up to $2.5 billion of the Company’s common stock through December 31, 2017. As of March 31, 2016, the Company had $2.2 billion remaining under its share repurchase authorization.

The Company may also reacquire shares of its common stock under its share-based compensation plans related to restricted stock awards and certain option exercises. The holders of restricted shares may elect to surrender a portion of their shares on the vesting date to cover their income tax obligation. These vested restricted shares are reacquired by the Company and the Company’s payment of the holders’ income tax obligations are recorded as a treasury share purchase. For both the three months ended March 31, 2016 and 2015, the Company reacquired 0.3 million shares of its common stock through the surrender of shares upon vesting and paid in the aggregate $26 million and $43 million, respectively, related to the holders’ income tax obligations on the vesting date. Option holders may elect to net settle their vested awards resulting in the surrender of the number of shares required to cover the strike price and tax obligation of the options exercised. These shares are reacquired by the Company and recorded as treasury shares. For the three months ended March 31, 2016 and 2015, the Company reacquired 0.1 million shares and 0.4 million shares, respectively, of its common stock through the net settlement of options for an aggregate value of $8 million and $51 million, respectively.

During the three months ended March 31, 2016 and 2015, the Company reissued 0.9 million and 1.0 million treasury shares, respectively, for restricted stock award grants, performance share units and issuance of shares vested under advisor deferred compensation plans.